121 related articles for article (PubMed ID: 3346876)
1. Synthesis of arginine-vasopressins, modified in positions 1 and 2, as antagonists of the vasopressor response to the parent hormone.
Lammek B; Rekowski P; Kupryszewski G; Melin P; Ragnarsson U
J Med Chem; 1988 Mar; 31(3):603-6. PubMed ID: 3346876
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
Lammek B; Derdowska I; Melin P
Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and some pharmacological properties of three new analogues of arginine-vasopressin modified in positions 1,2,4 and 9.
Lammek B; Derdowska I; Melin P
Pol J Pharmacol Pharm; 1989; 41(1):97-102. PubMed ID: 2587442
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
6. [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),4-valine,-8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin.
Lowbridge J; Manning M; Haldar J; Sawyer WH
J Med Chem; 1978 Mar; 21(3):313-5. PubMed ID: 628009
[TBL] [Abstract][Full Text] [Related]
7. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
Bankowski K; Manning M; Haldar J; Sawyer WH
J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
[TBL] [Abstract][Full Text] [Related]
8. [1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin.
Kruszynski M; Lammek B; Manning M; Seto J; Haldar J; Sawyer WH
J Med Chem; 1980 Apr; 23(4):364-8. PubMed ID: 6892930
[No Abstract] [Full Text] [Related]
9. Synthesis and some pharmacologic properties of five novel V1 or V1/V2 antagonists of AVP.
Lammek B; Wang YX; Derdowska I; Franco R; Gavras H
Peptides; 1989; 10(5):1109-12. PubMed ID: 2608555
[TBL] [Abstract][Full Text] [Related]
10. Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
Manning M; Olma A; Klis WA; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1982 Jan; 25(1):45-50. PubMed ID: 7086821
[TBL] [Abstract][Full Text] [Related]
11. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
12. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
13. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
[TBL] [Abstract][Full Text] [Related]
14. Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kruszynski M; Seto J; Sawyer WH
J Med Chem; 1982 Apr; 25(4):408-14. PubMed ID: 7069719
[No Abstract] [Full Text] [Related]
15. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
Lowbridge J; Manning M; Haldar J; Sawyer W
J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
[TBL] [Abstract][Full Text] [Related]
16. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
Varga C; Somlai C; Baláspiri L; László FA
Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
[TBL] [Abstract][Full Text] [Related]
17. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
[TBL] [Abstract][Full Text] [Related]
18. Suppression of natriferic activity of the vasopressin molecule by modifications in positions 1, 2 and 4.
Bakos P; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
Gen Physiol Biophys; 1990 Dec; 9(6):605-13. PubMed ID: 2079200
[TBL] [Abstract][Full Text] [Related]
19. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
20. Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1.
Lammek B; Wang YX; Franco R; Gavras I; Gavras H
J Pharm Pharmacol; 1991 Jan; 43(1):40-2. PubMed ID: 1676057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
